product

Microcrystalline cellulose (MCC) series products

Our company's position in the pharmaceutical excipient business is to provide high-quality excipients for domestic pharmaceutical companies which can substitute the imported excipients and help domestic pharmaceutical company to develop pharmaceutical technology, improve the quality of their drug products and promote their company to fully integrate with the global standards.

DESU ? is our registered trade name of microcrystalline cellulose (MCC) series products. The manufacture processes of MCC are compliance with the global GMP requirements. The excipients’ quality meets the EP/USP/CP standards. Due to the different functional requirements of excipients for the different drug products,11 MCC excipients with different particle size, water content and bulk density have been developed to specifically meet the need in various drug production. 

1. Product specification and performance

2. Performance and process research

Based on the knowledge of drug research and development and deep understanding the correlation between DESU ? series and drug formulation, WestPoint Medicine has designed a R&D system and a number of testing data have been generated through experimental drug product models. These data can be a good guide for the application of DESU ? series excipients in drug formulation and production.